The latest closing stock price for Design Therapeutics as of September 19, 2024 is 5.86.
An investor who bought $1,000 worth of Design Therapeutics stock at the IPO in 2021 would have $-859 today, roughly -1 times their original investment - a -47.92% compound annual growth rate over 3 years.
The all-time high Design Therapeutics stock closing price was 41.49 on March 26, 2021.
The Design Therapeutics 52-week high stock price is 6.91, which is 17.9% above the current share price.
The Design Therapeutics 52-week low stock price is 1.96, which is 66.6% below the current share price.
The average Design Therapeutics stock price for the last 52 weeks is 3.32.
An investor who bought $1,000 worth of Design Therapeutics stock at the IPO in 2021 would have $-859 today, roughly -1 times their original investment - a -47.92% compound annual growth rate over 3 years.
The all-time high Design Therapeutics stock closing price was 41.49 on March 26, 2021.
The Design Therapeutics 52-week high stock price is 6.91, which is 17.9% above the current share price.
The Design Therapeutics 52-week low stock price is 1.96, which is 66.6% below the current share price.
The average Design Therapeutics stock price for the last 52 weeks is 3.32.